⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 19, 2025Hepatology

Unlocking immunity’s memory: Epigenetic keys to HBV control

Brett M. McGettigan

View at Publisher

Ask AI

Bookmark

Share

Key Points

Immunity’s memory is crucial for effective control of HBV, impacting treatment strategies.
Key findings highlight the role of epigenetic changes in immune response, providing new insights.
Analysis of immune cell behavior demonstrates significant implications for developing HBV therapies.
Understanding these mechanisms may enable targeted interventions to enhance HBV management.

Implication

Observational analysis reveals epigenetic mechanisms influencing immunity and HBV control, suggesting potential therapeutic targets.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Brett M. McGettigan (2025) studied this question.

synapsesocial.com/papers/68c1cc3754b1d3bfb60f475e https://doi.org/10.1097/hep.0000000000001455

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Reversal of immune exhaustion for functional cure of chronic hepatitis B: Is the time right?2024
2Spatially-resolved immune drivers of HBV-associated HCC relapse2024
3HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infectionOriginal Research · 2026
4Epigenetic Rewiring and T Cell Exhaustion in HBV-induced HCC with Implications for Precision TherapiesOriginal Research · 2026 · 1 citations
5Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition2024

More related papers

Decoding HBV-specific adaptive immunity: from natural clearance to cure2025
Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance2013
The Intrinsic Innate Immunity of Hepatocytes Suppresses HBV Replication and Is Antagonized by HBx2025

More from Hepatology

AASLD AGA clinical Practice Guideline on management of primary biliary cholangitisThu,
Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled studyThu,